VKH
ONSIW

Virtu KCG Holdings’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Virtu KCG Holdings’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$32K Buy
+186,109
New +$91.8K ﹤0.01% 2672

Other funds holding ONSIW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu KCG Holdings's ONSIW Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q2 2017: 186,109 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2672 among its holdings.

10 funds tracked by Wall St. Rank hold ONSIW as of Q2 2017.

  • Virtu KCG Holdings held 186,109 shares of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 worth $32K as of Q2 2017.
  • Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 was a new Virtu KCG Holdings position in Q2 2017.
  • Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2672 holding.
  • 10 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.